Aldeyra Therapeutics Inc (NASDAQ:ALDX)

9.10
Delayed Data
As of Jul 23
 -0.08 / -0.87%
Today’s Change
5.53
Today|||52-Week Range
15.95
+32.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-10.8M-10.6M-15.6M-13.3M
 
 
 
 
 
Depreciation18.9K22.8K24.2K24.0K
 
 
 
 
 
Total Other Cash Flow1.1M954.1K7.9M1.9M
 
 
 
 
 
Funds From Operations-9.6M-9.7M-9.0M-11.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.9M-1.7M4.0M1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-7.7M-7.9M-13.0M-12.8M
 
 
 
 
 
 
InvestingIncrease In Investments-9.5M-38.2M-8.4M-13.1M
 
 
 
 
 
Decrease In Investments9.5M9.2M17.0M21.0M
 
 
 
 
 
Capital Expenditures-47.6K-14.6K-4.9K-4.6K
 
 
 
 
 
Fixed Asset Disposal------562.4K
 
 
Net Assets From Acquisitions 0.00--562.4K--
 
 
Net Cash Flow Investing-21.3K-29.0M9.2M7.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.2M67.6M807.6K-7.5K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.001.4M0.000.00
 
 
Net Cash Flow - Financing1.2M66.2M807.6K-7.5K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-6.6M29.3M-3.1M-4.9M